Colin, Andrew A <br/><br/>
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.  [electronic resource] 

 -  Pediatric pulmonology  Jun 2010 
 - 626-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Comment 
<br/><br/><label>ISSN: </label>1099-0496 
<br/><br/><label>Standard No.: </label>10.1002/ppul.21222  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Amikacin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Clarithromycin--administration & dosage<br/>Cystic Fibrosis--drug therapy<br/>Drug Therapy, Combination<br/>Female<br/>Forced Expiratory Volume<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Humans<br/>Mycobacterium--drug effects<br/>Mycobacterium Infections--drug therapy<br/>Nebulizers and Vaporizers<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Stenotrophomonas maltophilia--drug effects